Acutaas Chemicals Ltd.

Financial

	Acutaas Chemicals	Supriya Lifescience	Aether Industries
Operational Metrics
Financials
5 yr Average ROE	18.21 %	29.47 %	14.21 %
5yr average Equity Multiplier	1.75	1.48	1.42
5yr Average Asset Turnover Ratio	0.82	0.74	0.5
5yr Avg Net Profit Margin	12.12 %	24.83 %	17.43 %
Price to Book	8.12	5.24	4.42
P/E	56.28	29.35	56.05
5yr Avg Cash Conversion Cycle	58.6 Days	10.2 Days	217.24 Days
Inventory Days	65.78 Days	54.74 Days	132.13 Days
Days Receivable	111.06 Days	55.39 Days	149.84 Days
Days Payable	142.05 Days	115.12 Days	100.24 Days
5yr Average Interest Coverage Ratio	19.71	36.33	20.43
5yr Avg ROCE	22.58 %	37.03 %	16.82 %
5yr Avg Operating Profit Margin	19.73 %	34.97 %	26.4 %
5 yr average Debt to Equity	0.34	0.17	0.27
5yr CAGR Net Profit	9.26 %	10.17 %	-5.41 %
5yr Average Return on Assets	10.12 %	18.81 %	9.01 %
Shareholdings
Promoter Holding	32.66 %	68.3 %	75.0 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.75 %	0.06 %	-12.09 %
Change in Mutual Fund Holding (3 Yrs)	13.52 %	-2.44 %	4.9 %

Business

	Acutaas Chemicals	Supriya Lifescience	Aether Industries
Product Wise Break-Up	Product Wise Break-Up Pharma Intermediates 80.02 Specialty Chemicals 19.98 Pharmaceuticals 0 2-Methoxy-6-Chlorotoluene (MCT) 0 0 0 0 Thiophene-2-Ethanol (T2E) 0 4-(2-Methoxyethyl) Phenol (4MEP) 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 Bifenthrin Alcohol (BFA) 0 CRAMS 0	Product Wise Break-Up Thiophene-2-Ethanol (T2E) 0 Bifenthrin Alcohol (BFA) 0 Pharmaceuticals 100.0 0 Pharma Intermediates 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 4-(2-Methoxyethyl) Phenol (4MEP) 0 0 CRAMS 0 0 2-Methoxy-6-Chlorotoluene (MCT) 0 Specialty Chemicals 0	Product Wise Break-Up Thiophene-2-Ethanol (T2E) 0 Bifenthrin Alcohol (BFA) 15.18 Pharmaceuticals 0 3-Methoxy-2-Methyllenzoyl Chloride (MMBC) 10.74 Pharma Intermediates 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 4-(2-Methoxyethyl) Phenol (4MEP) 16.01 0 CRAMS 0 0 2-Methoxy-6-Chlorotoluene (MCT) 0 Specialty Chemicals 0 Others 58.07
Location Wise Break-Up	Location Wise Break-Up India 44.0 Finland 18.6 Italy 14.2 China 3.9 Germany 3.4 Spain 2.5 Israel 1.9 France 0 North America 0 LAC 0 Europe 0 Japan 0 Netherlands 0 Belgium 0 USA 0 Others 11.5	Location Wise Break-Up Israel 0 Finland 0 France 0 China 0 Germany 0 North America 2.0 Europe 36.0 Japan 0 Spain 0 Latin America 26.0 USA 0 Belgium 0 India 0 Italy 0 Netherlands 0 Others 36.0	Location Wise Break-Up Israel 0 Finland 0 France 0 China 0.75 Germany 7.24 North America 0 Europe 0 Japan 3.51 Spain 3.89 LAC 0 USA 5.73 Belgium 0 India 64.05 Italy 10.78 Netherlands 0.93 Others 3.12
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-depressant 27.99 Anti-retroviral 21.36 Anti-coagulant 6.73 Anti-malarial 0 Anti-allergic 0 Anti-Asthmatic 0 Vitamins 0 Anti-histamine 0 Analgesic/Anesthetic 0 Others 43.92	Therapeutic Area Break-Up Analgesic/Anesthetic 49.0 Anti-coagulant 0 Anti-depressant 0 Anti-allergic 4.0 Anti-Asthmatic 7.0 Anti-retroviral 0 Anti-malarial 0 Vitamins 11.0 Anti-histamine 11.0 Others 18.0	-
Verticals	Verticals Oil & Gas 0 Photography 0 Coatings 0 Material Science 0 Agro 0 Pharma 0 Others 100	-	Verticals Material Science 20.77 Oil & Gas 13.74 Coatings 2.63 Pharma 38.33 Agro 17.2 Photography 1.54 Others 5.79
Acute vs Chronic	Acute vs Chronic Chronic 95.0 Acute 5.0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 86.96 Others 13.04	-	-
API Break-Up	API Break-Up Trazodone 25.5 Dolutegravir 24.15 Oxcarbamazepine 6.69 Vortioxetine 4.87 Nintedanib 4.51 Zonisamide / Warfarin 4.29 Entacapone 3.52 Darulutamide 2.88 Celecoxib 2.81 Diclofenac Sodium 2.76 Quetiapine 2.63 Rivaroxaban 1.17 Dabigatran 1.02 Pazopanib 0.98 Apixaban 0.88 Others 11.34	-	-

Acutaas Chemicals Ltd.

SIGN UP FOR FREE